🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 154 (from laksa187)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa154.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.investing.com/academy/stock-picks/top-stocks-to-buy/\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.investing.com/academy/stock-picks/top-stocks-to-buy/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/","crawl_time":1773831561,"first_indexed_time":1693502652,"http_code":200,"src_unparsed":"com,investing!www,\/academy\/stock-picks\/top-stocks-to-buy\/ s443","src_root_hash":"11324614435800175354","history_drop_reason":null,"meta_title":"Top 5 US Stocks To Buy In February 2026 - Investing.com","meta_descriptions":["Get information and actionable insights on the best top stocks to buy this month, based on multiple metrics and expert analysis."],"attrs_boilerpipe_text":"Narrowing down the right stocks to buy based on multiple metrics is almost impossible without a solid methodology – which is where InvestingPro comes in.\nSo what are the best stocks to add your watchlist for having solid financial health\nand\ngrowth opportunity? Read below to see which great stocks have been suggested this month by our InvestingPro AI\/Analyst hybrid.\nOur top stock picks for this month are carefully selected to navigate stock market trends, opportunities and threats – continuing to focus on stocks that display strong fundamentals and resilience in the face of fluctuating economic conditions.\nOur Stock-Picking Methodology\nCopied\nCopy To Clipboard\nThese 5 stocks are our top Pro Picks for this month, taken from\nS&P 500\n-listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary\nfair value estimates\n(based on 5 overlaid investing models) and analyst assessments.\nLearn More 📜\nThe term “undervalued stocks” refers to stocks that are trading at a price below their intrinsic value or growth potential. Investors often look for undervalued stocks because, over the long term, the market will likely recognize the company’s true value, leading to a rise in the stock price and providing profit opportunities.\nAll of these names have earned InvestingPro health scores of well above 3.00 (Good, Great or Excellent), which for the last 7 years has indicated\noutperformance vs. the S&P 500\n. A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector.\nCopied\nCopy To Clipboard\nBest US Stocks This Month\nInvestingPro Health Score\n(Good, Great, or Excellent)\nHarmony Biosciences (\nHRMY\n)\nExcellent\nCal-Main Foods Inc (\nCALM\n)\nExcellent\nSNDL Inc (\nSNDL\n)\nGreat\nDanaos Corporation (\nDAC\n)\nGreat\nLuLu Lemon (\nLULU\n)\nGood\n* All data correct as of January 28th, 2026\nImportantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a\ncurrent potential upside of more than 20%\n. So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration.\nHarmony Biosciences (\nHRMY\n):\nCopied\nCopy To Clipboard\nInvestingPro health score\n: Excellent\nInvestingPro average fair value: $51.37 \/ 39.5% upside\nFair value confidence: High\nIndustry: Healthcare \/ Pharmaceuticals\nHarmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for February 2026. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of January 2025, Harmony Biosciences has a market capitalization of approximately $2.12 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain.\nThe company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P\/E ratio is reported at 11.4, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 39.5% potential upside) due to anticipated product launches and expanding market reach.\nHarmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge.\nOverall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs.\nCal-Maine Foods Inc (\nCALM\n):\nCopied\nCopy To Clipboard\nInvestingPro health score\n: Excellent\nInvestingPro average fair value: $102.12 \/ 26.9% upside\nFair value confidence: High\nIndustry: Consumer Staples \/ Food Products\nCal-Maine Foods Inc earns their second month our list as stock pick for February 2026. As of the latest quarter, the company boasts a market capitalization of around $3.83 billion, marking it as a notable player in the consumer staples (food). Cal-Maine Foods specializes the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods.\nThe company pays a quarterly dividend of (currently) 3.6%, providing investors with steady income alongside potential capital appreciation. With a P\/E ratio of 3.3, Cal-Maine Foods appears relatively undervalued compared to industry peers, hinting at potential upside, especially if egg market production remains robust.\nCal-Maine Foods maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 0.0% (which is common for them), which supports its operational diligence. Investors considering this stock should be aware of the volatility resilience associated with staple products, highlighted by their current 1-Year Beta of just 0.23.\nOverall, Cal-Maine Foods’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a resilient sector with the potential for both income and growth.\nSNDL Inc (\nSNDL\n):\nCopied\nCopy To Clipboard\nInvestingPro health score\n: Great\nInvestingPro average fair value: $2.35 \/ 43.2% upside\nFair value confidence: Medium\nIndustry: Healthcare \/ Pharmaceuticals\nSNDL Inc (SNDL) presents a solid investment opportunity as we head into February 2026, especially for investors seeking opportunities in the pharmaceuticals sector. With a market capitalization of roughly $422.3 million as of the end of January, SNDL is a small player with significant potential upsides.\nWhile SDNL doesn’t pay a shareholder dividend, this shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. While the current P\/E ratio is -6.3, (an improvement again from last month) the company is looking on track to be profitable this year with a high shareholder yield and strong liquid assets.\nSpeaking of risks, however, it’s important to note that SNDL operates in sectors characterized by regulatory volatility and competitive dynamics, which can lead to significant stock price fluctuations.\nDespite these challenges, SNDL has managed its debt levels effectively, ensuring financial stability as it explores new markets and products. This disciplined approach to expansion, combined with potential new legislative changes favoring cannabis legalization, could catalyze growth and enhance shareholder value. Overall, SNDL Inc. presents a dynamic investment opportunity for those looking to leverage the evolving landscape of the cannabis and alcohol sectors.\nDanaos Corp (\nDAC\n):\nCopied\nCopy To Clipboard\nInvestingPro health score\n: Great\nInvestingPro average fair value: $126.20 \/ 25.3% upside\nFair value confidence: High\nIndustry: Marine Transportation\nDanaos Corp (DAC) stands out as a noteworthy stock pick for February 2026, particularly for investors interested in the maritime shipping sector. As of the close of January, Danaos boasts a market capitalization of approximately $1.84 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics.\nDanaos offers an attractive dividend yield, currently at 3.6%, providing an added incentive for income-focused investors. The company maintains a P\/E ratio of 3.9, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 25% for those looking to capitalize on market inefficiencies.\nIn terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions.\nOverall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects.\nLuLu Lemon (\nLULU\n)\n:\nCopied\nCopy To Clipboard\nInvestingPro health score\n: Good\nInvestingPro average fair value: $290.94 \/ 52.3% upside\nFair value confidence: Medium\nIndustry: Textiles, Apparel & Luxury Goods\nFor investors targeting the consumer discretionary sector, Lululemon Athletica (LULU) presents a compelling growth story. As a global leader in athletic apparel and lifestyle products, the company boasts a substantial market capitalization of approximately $22.41 billion (as of the end of January 2026). Its current Price-to-Earnings (P\/E) ratio stands at 12.9, reflecting strong investor confidence in its future earnings potential and premium brand positioning, which was reinforced by solid performance in the last quarter.\nFinancially, Lululemon operates with a very strong balance sheet and minimal debt, allowing it to self-fund its aggressive expansion into new product categories and international markets. The company does not currently pay a dividend, instead prioritizing the reinvestment of profits to fuel this growth.\nAnalysts see a potential upside of just over 52% for the stock, driven by continued brand loyalty and successful market penetration. With a beta of 1.28, the stock exhibits a similar volatility (just slightly higher) than the overall market, which is uncharacteristic of a high-growth consumer brand. For investors with a long-term perspective, Lululemon’s powerful brand equity and consistent execution make it an attractive pick.\nHow To Find More Of The Best US Stocks\nCopied\nCopy To Clipboard\nUse The InvestingPro Stock Screener To Outsmart The Market! 🛠️ 📈💸\nGain instant access to\nover 1,200 fundamental metrics\nfor thousands of listed companies. Plus:\n✓ Easily and quickly find the best undervalued stocks for your portfolio\n✓ Competitor comparison tools\n✓ Evaluate stocks with 14+ proven financial models\n✓ Copy stock picks and weightings from top investors (including Warren Buffett)\n✓ Use filters to find stocks that perfectly match your strategy\nTry InvestingPro and outsmart the market!\nPrevious Investing Stock Picks for US Markets\nCopied\nCopy To Clipboard\nIf you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months.\nRemember 📌\nThe health scores and these stocks’ place on our opportunities list were correct at the time of the original posting month. It’s important for investors to check any updated information, which can be done at the click of a button through\nInvestingPro\n.\nPrevious Top US Stocks to Watch in 2024\nTop November\/December 2024 Stock\ns To Watch\nInvestingPro Health Score\nHarmony Biosciences (\nHRMY\n)\n3.97\n\/ 5\nInternational Seaways Inc (\nINSW\n)\n3.48\n\/ 5\nWhite Mountain Insurance (\nWTM\n)\n3.27\n\/ 5\nDanaos Corporation (\nDAC\n)\n3.29\n\/ 5\nMI Homes (\nMHO\n)\n3.08\n\/ 5\nTop October 2024 Stocks To Watch\nInvestingPro Health Score\nHarmony Biosciences (\nHRMY\n)\n3.89\n\/ 5\nInternational Seaways Inc (\nINSW\n)\n3.71\n\/ 5\nWhite Mountain Insurance (\nWTM\n)\n3.13\n\/ 5\nDanaos Corporation (\nDAC\n)\n3.47\n\/ 5\nTop September 2024 Stocks To Watch\nInvestingPro Health Score\nTop September Stock\nInvestingPro Health Score\nHarmony Biosciences (\nHRMY\n)\n3.86\n\/ 5\nInternational Seaways Inc (\nINSW\n)\n3.60\n\/ 5\nWhite Mountain Insurance (\nWTM\n)\n3.18\n\/ 5\nDanaos Corporation (\nDAC\n)\n3.35\n\/ 5\nKB Home (\nKBH\n)\n3.23\n\/ 5\nTop August 2024 Stocks To Watch\nInvestingPro Health Score\nHarmony Biosciences (\nHRMY\n)\n3.94\n\/ 5\nInternational Seaways Inc (\nINSW\n)\n3.73\n\/ 5\nMeritage Corporation (\nMTH\n)\n3.32\n\/ 5\nDanaos Corporation (\nDAC\n)\n3.57\n\/ 5\nKB Home (\nKBH\n)\n3.38\n\/ 5\nTop July 2024 Stocks To Watch\nInvestingPro Health Score\nHarmony Biosciences (\nHRMY\n)\n3.95\n\/ 5\nInternational Seaways Inc (\nINSW\n)\n3.80\n\/ 5\nMeritage Corporation (\nMTH\n)\n3.10\n\/ 5\nDanaos Corporation (\nDAC\n)\n3.75\n\/ 5\nKB Home (\nKBH\n)\n3.38\n\/ 5\nTop June 2024 Stocks To Watch\nInvestingPro Health Score\nTsakos Energy Nav. Ltd (\nTNP\n)\n3.33\n\/ 5\nInternational Seaways Inc (\nINSW\n)\n3.86\n\/ 5\nMeritage Corporation (\nMTH\n)\n3.15\n\/ 5\nDanaos Corporation (\nDAC\n)\n3.87\n\/ 5\nCVR Partners (\nUAN\n)\n3.33\n\/ 5\nTop March 2024 Stocks To Watch\nInvestingPro Health Score\nXpel Inc (\nXPEL\n)\n3.14\n \/ 5\nTeekay Tankers (\nTNK\n)\n3.71\n \/ 5\nSimply Good Foods (\nSMPL\n)\n3.02\n \/ 5\nUnited Therapeutics Corp (\nUTHR\n)\n3.72\n \/ 5\nThe Andersons Inc (\nANDE\n)\n3.31\n \/ 5\nTop January 2024 Stocks To Watch\nInvestingPro Health Score\nTeekay Tankers (\nTNK\n)\n3.81\n\/ 5\nMueller Industries (\nMLI\n)\n3.88\n\/ 5\nDanaos (\nDAC\n)\n3.89\n\/ 5\nMedifast (\nMED\n)\n3.30\n\/ 5\nDaqo New Energy (\nDQ\n)\n3.89\n\/ 5\nRemember 📌\nPast performance does not guarantee future success, and trading in financial instruments and\/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.","attrs_markdown":"[Investing.com](https:\/\/www.investing.com\/)\n\n- [Academy Center](https:\/\/www.investing.com\/academy\/)\n\n- [Markets](https:\/\/www.investing.com\/markets\/)\n- [News](https:\/\/www.investing.com\/news)\n- [Analysis](https:\/\/www.investing.com\/analysis)\n- [Charts](https:\/\/www.investing.com\/charts)\n- [Technical](https:\/\/www.investing.com\/technical\/)\n- [Tools](https:\/\/www.investing.com\/tools\/)\n- [Watchlist](https:\/\/www.investing.com\/portfolio\/)\n- [Webinars](https:\/\/www.investing.com\/education\/webinars)\n- [InvestingPro](https:\/\/www.investing.com\/pro?entry=academy)\n\n[Academy](https:\/\/www.investing.com\/academy\/)\n\n- [Stocks](https:\/\/www.investing.com\/academy\/stocks\/)\n- [Crypto](https:\/\/www.investing.com\/academy\/crypto\/)\n- [Trading](https:\/\/www.investing.com\/academy\/trading\/)\n- [ETFs](https:\/\/www.investing.com\/academy\/etfs\/)\n- [Currencies](https:\/\/www.investing.com\/academy\/currencies\/)\n- [Analysis](https:\/\/www.investing.com\/academy\/analysis\/)\n- [Statistics](https:\/\/www.investing.com\/academy\/statistics\/)\n- [Stock Picks](https:\/\/www.investing.com\/academy\/stock-picks\/)\n- [Financial Terms](https:\/\/www.investing.com\/academy\/financial-terms\/)\n- [Global Stock Picks](https:\/\/www.investing.com\/academy\/global-stock-picks\/)\n- [InvestingPro 101](https:\/\/www.investing.com\/academy\/investing-pro\/)\n- [Tools](https:\/\/www.investing.com\/academy\/tools\/)\n\nTable of contents\n\n- [Our Stock-Picking Methodology](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#our-stock-picking-methodology)\n- [5 Stocks To Consider In February 2026](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#5-stocks-to-consider-in-february-2026)\n- [Harmony Biosciences (HRMY):](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#harmony-biosciences-hrmy)\n- [Cal-Maine Foods Inc (CALM):](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#cal-maine-foods-inc-calm)\n- [SNDL Inc (SNDL):](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#sndl-inc-sndl)\n- [Danaos Corp (DAC):](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#danaos-corp-dac)\n- [LuLu Lemon (LULU):](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#lulu-lemon-lulu)\n- [How To Find More Of The Best US Stocks](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#how-to-find-more-of-the-best-us-stocks)\n- [Previous Investing Stock Picks for US Markets](https:\/\/www.investing.com\/academy\/stock-picks\/top-stocks-to-buy\/#previous-investing-stock-picks-for-us-markets)\n\n[Academy Center](https:\/\/www.investing.com\/academy\/) \\> [Stock Picks](https:\/\/www.investing.com\/academy\/stock-picks\/)\n\nStock Picks  Beginner\n# Top 5 US Stocks To Buy In February 2026\nwritten by\n\n[Sara-Jayne Slack](https:\/\/www.investing.com\/academy\/author\/sara-jayne-slack\/)\n\n![arrow-top](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/arrow-top.png)\n\n![](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2023\/08\/Sara-Jayne.png)\n\nexpertise:\n\nWealth Management, Personal Finance\n\ncurrently:\n\nSEO Specialist (UK Market) \\| Investing.com\n\neducation:\n\nBA & MA in English Studies, University of Leicester \\| Financial Markets and Investment Management, University of Geneva\n\n[See Full Bio](https:\/\/www.investing.com\/academy\/author\/sara-jayne-slack\/)\n\n\\| updated\n\nJanuary 26, 2026\n\n![Blog header showing screenshot from InvestingPro with the blog title on the right](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2023\/08\/Top-Stocks-Monthly.png)\n\nNarrowing down the right stocks to buy based on multiple metrics is almost impossible without a solid methodology – which is where InvestingPro comes in.\n\nSo what are the best stocks to add your watchlist for having solid financial health *and* growth opportunity? Read below to see which great stocks have been suggested this month by our InvestingPro AI\/Analyst hybrid.\n\nOur top stock picks for this month are carefully selected to navigate stock market trends, opportunities and threats – continuing to focus on stocks that display strong fundamentals and resilience in the face of fluctuating economic conditions.\n\n## **Our Stock-Picking Methodology**\nCopied\n\nThese 5 stocks are our top Pro Picks for this month, taken from [S\\&P 500](https:\/\/www.investing.com\/indices\/us-spx-500)\\-listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary [fair value estimates](https:\/\/www.investing.com\/academy\/analysis\/fair-value-investing-stocks\/) (based on 5 overlaid investing models) and analyst assessments.\n\nLearn More 📜\n\nThe term “undervalued stocks” refers to stocks that are trading at a price below their intrinsic value or growth potential. Investors often look for undervalued stocks because, over the long term, the market will likely recognize the company’s true value, leading to a rise in the stock price and providing profit opportunities.\n\nAll of these names have earned InvestingPro health scores of well above 3.00 (Good, Great or Excellent), which for the last 7 years has indicated **outperformance vs. the S\\&P 500**. A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector.\n\n## **5 Stocks To Consider In** February 2026\nCopied\n\n| Best US Stocks This Month | **InvestingPro Health Score** (Good, Great, or Excellent) |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [Excellent](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) |\n| Cal-Main Foods Inc ([CALM](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM?entry=academy)) | [Excellent](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM\/health?entry=academy) |\n| SNDL Inc ([SNDL](https:\/\/www.investing.com\/equities\/sundial-growers-inc)) | [Great](https:\/\/www.investing.com\/pro\/NASDAQCM:SNDL\/health?entry=academy) |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [Great](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) |\n| LuLu Lemon ([LULU](https:\/\/www.investing.com\/equities\/lululemon-athletica)) | [Good](https:\/\/www.investing.com\/pro\/NASDAQGS:LULU\/health?entry=academy) |\n\n\\* All data correct as of January 28th, 2026\n\nImportantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a **current potential upside of more than 20%**. So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration.\n\n[![InvestingPro Cyber Monday 60% Off Banner](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2023\/11\/Maximize-Profit-Potential-Today-Banner.png)](https:\/\/www.investing.com\/pro\/pricing?entry=academy)\n\n## ****Harmony Biosciences (**[**HRMY**](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)**):****\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy): Excellent\n- InvestingPro average fair value: \\$51.37 \/ 39.5% upside\n- Fair value confidence: High\n- Industry: Healthcare \/ Pharmaceuticals\n\nHarmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for February 2026. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of January 2025, Harmony Biosciences has a market capitalization of approximately \\$2.12 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain.\n\nThe company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P\/E ratio is reported at 11.4, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 39.5% potential upside) due to anticipated product launches and expanding market reach.\n\nHarmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge.\n\nOverall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs.\n\n## **Cal-Maine Foods Inc ([CALM](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM?entry=academy)):**\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM\/health?entry=academy): Excellent\n- InvestingPro average fair value: \\$102.12 \/ 26.9% upside\n- Fair value confidence: High\n- Industry: Consumer Staples \/ Food Products\n\nCal-Maine Foods Inc earns their second month our list as stock pick for February 2026. As of the latest quarter, the company boasts a market capitalization of around \\$3.83 billion, marking it as a notable player in the consumer staples (food). Cal-Maine Foods specializes the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods.\n\nThe company pays a quarterly dividend of (currently) 3.6%, providing investors with steady income alongside potential capital appreciation. With a P\/E ratio of 3.3, Cal-Maine Foods appears relatively undervalued compared to industry peers, hinting at potential upside, especially if egg market production remains robust.\n\nCal-Maine Foods maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 0.0% (which is common for them), which supports its operational diligence. Investors considering this stock should be aware of the volatility resilience associated with staple products, highlighted by their current 1-Year Beta of just 0.23.\n\nOverall, Cal-Maine Foods’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a resilient sector with the potential for both income and growth.\n\n## **SNDL Inc ([SNDL](https:\/\/www.investing.com\/equities\/sundial-growers-inc)):**\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQCM:SNDL?entry=academy): Great\n- InvestingPro average fair value: \\$2.35 \/ 43.2% upside\n- Fair value confidence: Medium\n- Industry: Healthcare \/ Pharmaceuticals\n\nSNDL Inc (SNDL) presents a solid investment opportunity as we head into February 2026, especially for investors seeking opportunities in the pharmaceuticals sector. With a market capitalization of roughly \\$422.3 million as of the end of January, SNDL is a small player with significant potential upsides.\n\nWhile SDNL doesn’t pay a shareholder dividend, this shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. While the current P\/E ratio is -6.3, (an improvement again from last month) the company is looking on track to be profitable this year with a high shareholder yield and strong liquid assets.\n\nSpeaking of risks, however, it’s important to note that SNDL operates in sectors characterized by regulatory volatility and competitive dynamics, which can lead to significant stock price fluctuations.\n\nDespite these challenges, SNDL has managed its debt levels effectively, ensuring financial stability as it explores new markets and products. This disciplined approach to expansion, combined with potential new legislative changes favoring cannabis legalization, could catalyze growth and enhance shareholder value. Overall, SNDL Inc. presents a dynamic investment opportunity for those looking to leverage the evolving landscape of the cannabis and alcohol sectors.\n\n## **Danaos Corp (**[**DAC**](https:\/\/www.investing.com\/equities\/danaos-corp)**):**\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy): Great\n- InvestingPro average fair value: \\$126.20 \/ 25.3% upside\n- Fair value confidence: High\n- Industry: Marine Transportation\n\nDanaos Corp (DAC) stands out as a noteworthy stock pick for February 2026, particularly for investors interested in the maritime shipping sector. As of the close of January, Danaos boasts a market capitalization of approximately \\$1.84 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics.\n\nDanaos offers an attractive dividend yield, currently at 3.6%, providing an added incentive for income-focused investors. The company maintains a P\/E ratio of 3.9, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 25% for those looking to capitalize on market inefficiencies.\n\nIn terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions.\n\nOverall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects.\n\n## ******LuLu Lemon ([LULU](https:\/\/www.investing.com\/equities\/lululemon-athletica))**:****\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQGS:LULU\/health?entry=academy): Good\n- InvestingPro average fair value: \\$290.94 \/ 52.3% upside\n- Fair value confidence: Medium\n- Industry: Textiles, Apparel & Luxury Goods\n\nFor investors targeting the consumer discretionary sector, Lululemon Athletica (LULU) presents a compelling growth story. As a global leader in athletic apparel and lifestyle products, the company boasts a substantial market capitalization of approximately \\$22.41 billion (as of the end of January 2026). Its current Price-to-Earnings (P\/E) ratio stands at 12.9, reflecting strong investor confidence in its future earnings potential and premium brand positioning, which was reinforced by solid performance in the last quarter.\n\nFinancially, Lululemon operates with a very strong balance sheet and minimal debt, allowing it to self-fund its aggressive expansion into new product categories and international markets. The company does not currently pay a dividend, instead prioritizing the reinvestment of profits to fuel this growth.\n\nAnalysts see a potential upside of just over 52% for the stock, driven by continued brand loyalty and successful market penetration. With a beta of 1.28, the stock exhibits a similar volatility (just slightly higher) than the overall market, which is uncharacteristic of a high-growth consumer brand. For investors with a long-term perspective, Lululemon’s powerful brand equity and consistent execution make it an attractive pick.\n\n## How To Find More Of The Best US Stocks\nCopied\n\nUse The InvestingPro Stock Screener To Outsmart The Market! 🛠️ 📈💸\n\nGain instant access to **over 1,200 fundamental metrics** for thousands of listed companies. Plus:\n\n✓ Easily and quickly find the best undervalued stocks for your portfolio\n\n✓ Competitor comparison tools\n\n✓ Evaluate stocks with 14+ proven financial models\n\n✓ Copy stock picks and weightings from top investors (including Warren Buffett)\n\n✓ Use filters to find stocks that perfectly match your strategy\n\n[Try InvestingPro and outsmart the market\\!](https:\/\/www.investing.com\/pro\/pricing?entry=academy)\n\n## **Previous Investing Stock Picks for US Markets**\nCopied\n\nIf you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months.\n\nRemember 📌\n\nThe health scores and these stocks’ place on our opportunities list were correct at the time of the original posting month. It’s important for investors to check any updated information, which can be done at the click of a button through [InvestingPro](https:\/\/www.investing.com\/pro?entry=academy).\n### Previous Top US Stocks to Watch in 2024\n| **Top November\/December 2024 Stock**s To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.97](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.48](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| White Mountain Insurance ([WTM](https:\/\/www.investing.com\/equities\/white-mountains-insurance-group)) | [3\\.27](https:\/\/www.investing.com\/pro\/NYSE:WTM\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.29](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| MI Homes ([MHO](https:\/\/www.investing.com\/equities\/m-i-homes-inc)) | [3\\.08](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top October 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.89](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.71](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| White Mountain Insurance ([WTM](https:\/\/www.investing.com\/equities\/white-mountains-insurance-group)) | [3\\.13](https:\/\/www.investing.com\/pro\/NYSE:WTM\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.47](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n\n| Top September 2024 Stocks To Watch | InvestingPro Health Score |\n|---|---|\n| **Top September Stock** | **InvestingPro Health Score** |\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.86](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.60](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| White Mountain Insurance ([WTM](https:\/\/www.investing.com\/equities\/white-mountains-insurance-group)) | [3\\.18](https:\/\/www.investing.com\/pro\/NYSE:WTM\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.35](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| KB Home ([KBH](https:\/\/www.investing.com\/equities\/kb-home)) | [3\\.23](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top August 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.94](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.73](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| Meritage Corporation ([MTH](https:\/\/www.investing.com\/equities\/meritage-homes-corp)) | [3\\.32](https:\/\/www.investing.com\/pro\/NYSE:MTH\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.57](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| KB Home ([KBH](https:\/\/www.investing.com\/equities\/kb-home)) | [3\\.38](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top July 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.95](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.80](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| Meritage Corporation ([MTH](https:\/\/www.investing.com\/equities\/meritage-homes-corp)) | [3\\.10](https:\/\/www.investing.com\/pro\/NYSE:MTH\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.75](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| KB Home ([KBH](https:\/\/www.investing.com\/equities\/kb-home)) | [3\\.38](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top June 2024 Stocks To Watch | InvestingPro Health Score |\n|---|---|\n| Tsakos Energy Nav. Ltd ([TNP](https:\/\/www.investing.com\/equities\/tsakos-energy-navigation-ltd)) | [3\\.33](https:\/\/www.investing.com\/pro\/NYSE:TNP\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.86](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| Meritage Corporation ([MTH](https:\/\/www.investing.com\/equities\/meritage-homes-corp)) | [3\\.15](https:\/\/www.investing.com\/pro\/NYSE:MTH\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.87](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| CVR Partners ([UAN](https:\/\/www.investing.com\/equities\/cvr-partners-lp)) | [3\\.33](https:\/\/www.investing.com\/pro\/NYSE:UAN\/health?entry=academy) \/ 5 |\n\n| Top March 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Xpel Inc ([XPEL](https:\/\/www.investing.com\/equities\/xpel-inc)) | [3\\.14](https:\/\/www.investing.com\/pro\/NASDAQCM:XPEL\/health?entry=academy) \/ 5 |\n| Teekay Tankers ([TNK](https:\/\/www.investing.com\/equities\/teekay-tankers-ltd)) | [3\\.71](https:\/\/www.investing.com\/pro\/NYSE:TNK\/health?entry=academy) \/ 5 |\n| Simply Good Foods ([SMPL](https:\/\/www.investing.com\/equities\/simplicity)) | [3\\.02](https:\/\/www.investing.com\/pro\/NASDAQCM:SMPL\/health?entry=academy) \/ 5 |\n| United Therapeutics Corp ([UTHR](https:\/\/www.investing.com\/equities\/united-therapeutics-corp)) | [3\\.72](https:\/\/uk.investing.com\/pro\/NASDAQGS:UTHR\/health?entry=academy) \/ 5 |\n| The Andersons Inc ([ANDE](https:\/\/www.investing.com\/equities\/the-andersons)) | [3\\.31](https:\/\/uk.investing.com\/pro\/NASDAQGS:ANDE\/health?entry=academy) \/ 5 |\n\n| Top January 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Teekay Tankers ([TNK](https:\/\/www.investing.com\/equities\/teekay-tankers-ltd)) | [3\\.81](https:\/\/www.investing.com\/pro\/NYSE:TNK\/health?entry=academy) \/ 5 |\n| Mueller Industries ([MLI](https:\/\/www.investing.com\/equities\/mueller-industries-inc)) | [3\\.88](https:\/\/www.investing.com\/pro\/NYSE:MLI\/health?entry=academy) \/ 5 |\n| Danaos ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.89](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| Medifast ([MED](https:\/\/www.investing.com\/equities\/medifast-inc)) | [3\\.30](https:\/\/www.investing.com\/pro\/NYSE:MED\/health?entry=academy) \/ 5 |\n| Daqo New Energy ([DQ](https:\/\/www.investing.com\/equities\/daqq-new-energy-corp)) | [3\\.89](https:\/\/www.investing.com\/pro\/NYSE:DQ\/health?entry=academy) \/ 5 |\n\nRemember 📌\n\nPast performance does not guarantee future success, and trading in financial instruments and\/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.\n\n- Related\n- Recent\n\n[![]()](https:\/\/www.investing.com\/pro\/pricing?entry=academy)\n\n## Recent Articles\n[![](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2025\/12\/Top-10-Stocks-For-2026-150x150.png) Top 10 Stocks for 2026: Live Expert Analysis & Free Stock List While most investors chase the last AI winners of 2025, smart money is quietly rotating into completely different opportunities for 2026. The next 30 days](https:\/\/www.investing.com\/academy\/stock-picks\/top-ten-2026-stocks\/)\n\n[![](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2025\/08\/amd-image-150x150.jpg) Nvidia vs AMD: Stock Comparison Investing in technology stocks requires understanding not just current performance metrics but the fundamental strengths, market positioning, and long term potential of companies. When considering](https:\/\/www.investing.com\/academy\/stock-picks\/nvidia-vs-amd\/)\n\n[![](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2025\/08\/nvidia-vs-broadcom-150x150.jpg) Nvidia vs Broadcom Stock Comparison When navigating the semiconductor industry for investment opportunities, Nvidia and Broadcom often emerge as leading contenders for investor portfolios. Both companies represent significant forces in](https:\/\/www.investing.com\/academy\/stock-picks\/nvidia-vs-broadcom\/)\n\n[![](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2025\/08\/berkshire-hathaway-150x150.jpg) Berkshire Hathaway Class A vs. Class B: Understanding the Differences For investors interested in owning a piece of a legendary company like Berkshire Hathaway, the choice often comes down to two different share classes: Class](https:\/\/www.investing.com\/academy\/stock-picks\/berkshire-hathaway-class-a-vs-class-b\/)\n***\n### Install Our Apps\nScan the QR code or install from the link\n\n[![www.facebook.com](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/icon-apple.svg)App Store](https:\/\/app.appsflyer.com\/id909998122?pid=direct_inv&c=refactored&af_channel=%2F&af_adset=www&af_ad=footer&af_pmod_priority=null&af_sub_siteid=GA1.1.1440476105.1724666634&click_id=null&af_sub1=null&af_ad_id=null&af_sub2=null&af_sub3=null&af_sub4=null&af_sub5=null&af_keywords=null&af_adset_id=null) [![www.twitter.com](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/icon-google-play.svg)Google Play](https:\/\/app.appsflyer.com\/com.fusionmedia.investing?pid=direct_inv&c=refactored&af_channel=%2F&af_adset=www&af_ad=footer&af_pmod_priority=null&af_sub_siteid=GA1.1.1440476105.1724666634&click_id=null&af_sub1=null&af_ad_id=null&af_sub2=null&af_sub3=null&af_sub4=null&af_sub5=null&af_keywords=null&af_adset_id=null)\n***\n![www.investing.com](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/QR-Code.svg)\n\n- [Blog](https:\/\/www.investing.com\/blog)\n- [Mobile](https:\/\/www.investing.com\/mobile)\n- [Portfolio](https:\/\/www.investing.com\/portfolio)\n- [Widgets](https:\/\/www.investing.com\/webmaster-tools)\n- [About Us](https:\/\/www.investing.com\/about-us)\n- [Advertise](https:\/\/www.investingmediakit.com\/)\n- [Help & Support](https:\/\/www.investing.com\/about-us\/contact-us)\n- [Authors](https:\/\/www.investing.com\/lp\/authors)\n\n![Investing.com](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/logo.png)\n\n[![www.facebook.com](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/icon-facebook.svg)](https:\/\/www.facebook.com\/investingcom\/) [![www.twitter.com](https:\/\/academy.education.investing.com\/wp-content\/themes\/Ancelotti\/includes\/images\/icon-twitter.svg)](https:\/\/www.twitter.com\/investingcom)\n\nRisk Disclosure: Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.  \n   \n Fusion Media does not endorse any product or service and does not assume any liability regarding your interaction with any third party displayed on this site, including the nature, quality, supply or fitness for a particular purpose of the product or service, or any damage caused as a result of the use of such product or service.\n***\n© 2007-2026 Fusion Media Limited. All Rights Reserved\n\n- [Terms And Conditions](https:\/\/www.investing.com\/about-us\/terms-and-conditions\/)\n- [Privacy Policy](https:\/\/www.investing.com\/about-us\/privacy-policy\/)\n- [Risk Warning](https:\/\/www.investing.com\/about-us\/risk-warning\/)\n- [Cookie Preferences]()","attrs_readable_markdown":"Narrowing down the right stocks to buy based on multiple metrics is almost impossible without a solid methodology – which is where InvestingPro comes in.\n\nSo what are the best stocks to add your watchlist for having solid financial health *and* growth opportunity? Read below to see which great stocks have been suggested this month by our InvestingPro AI\/Analyst hybrid.\n\nOur top stock picks for this month are carefully selected to navigate stock market trends, opportunities and threats – continuing to focus on stocks that display strong fundamentals and resilience in the face of fluctuating economic conditions.\n\n## **Our Stock-Picking Methodology**\nCopied\n\nThese 5 stocks are our top Pro Picks for this month, taken from [S\\&P 500](https:\/\/www.investing.com\/indices\/us-spx-500)\\-listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary [fair value estimates](https:\/\/www.investing.com\/academy\/analysis\/fair-value-investing-stocks\/) (based on 5 overlaid investing models) and analyst assessments.\n\nLearn More 📜\n\nThe term “undervalued stocks” refers to stocks that are trading at a price below their intrinsic value or growth potential. Investors often look for undervalued stocks because, over the long term, the market will likely recognize the company’s true value, leading to a rise in the stock price and providing profit opportunities.\n\nAll of these names have earned InvestingPro health scores of well above 3.00 (Good, Great or Excellent), which for the last 7 years has indicated **outperformance vs. the S\\&P 500**. A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector.\n\nCopied\n\n| Best US Stocks This Month | **InvestingPro Health Score** (Good, Great, or Excellent) |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [Excellent](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) |\n| Cal-Main Foods Inc ([CALM](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM?entry=academy)) | [Excellent](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM\/health?entry=academy) |\n| SNDL Inc ([SNDL](https:\/\/www.investing.com\/equities\/sundial-growers-inc)) | [Great](https:\/\/www.investing.com\/pro\/NASDAQCM:SNDL\/health?entry=academy) |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [Great](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) |\n| LuLu Lemon ([LULU](https:\/\/www.investing.com\/equities\/lululemon-athletica)) | [Good](https:\/\/www.investing.com\/pro\/NASDAQGS:LULU\/health?entry=academy) |\n\n\\* All data correct as of January 28th, 2026\n\nImportantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a **current potential upside of more than 20%**. So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration.\n\n[![InvestingPro Cyber Monday 60% Off Banner](https:\/\/academy.education.investing.com\/wp-content\/uploads\/2023\/11\/Maximize-Profit-Potential-Today-Banner.png)](https:\/\/www.investing.com\/pro\/pricing?entry=academy)\n\n## ****Harmony Biosciences (**[**HRMY**](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)**):****\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy): Excellent\n- InvestingPro average fair value: \\$51.37 \/ 39.5% upside\n- Fair value confidence: High\n- Industry: Healthcare \/ Pharmaceuticals\n\nHarmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for February 2026. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of January 2025, Harmony Biosciences has a market capitalization of approximately \\$2.12 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain.\n\nThe company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P\/E ratio is reported at 11.4, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 39.5% potential upside) due to anticipated product launches and expanding market reach.\n\nHarmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge.\n\nOverall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs.\n\n## **Cal-Maine Foods Inc ([CALM](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM?entry=academy)):**\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQGS:CALM\/health?entry=academy): Excellent\n- InvestingPro average fair value: \\$102.12 \/ 26.9% upside\n- Fair value confidence: High\n- Industry: Consumer Staples \/ Food Products\n\nCal-Maine Foods Inc earns their second month our list as stock pick for February 2026. As of the latest quarter, the company boasts a market capitalization of around \\$3.83 billion, marking it as a notable player in the consumer staples (food). Cal-Maine Foods specializes the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods.\n\nThe company pays a quarterly dividend of (currently) 3.6%, providing investors with steady income alongside potential capital appreciation. With a P\/E ratio of 3.3, Cal-Maine Foods appears relatively undervalued compared to industry peers, hinting at potential upside, especially if egg market production remains robust.\n\nCal-Maine Foods maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 0.0% (which is common for them), which supports its operational diligence. Investors considering this stock should be aware of the volatility resilience associated with staple products, highlighted by their current 1-Year Beta of just 0.23.\n\nOverall, Cal-Maine Foods’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a resilient sector with the potential for both income and growth.\n\n## **SNDL Inc ([SNDL](https:\/\/www.investing.com\/equities\/sundial-growers-inc)):**\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQCM:SNDL?entry=academy): Great\n- InvestingPro average fair value: \\$2.35 \/ 43.2% upside\n- Fair value confidence: Medium\n- Industry: Healthcare \/ Pharmaceuticals\n\nSNDL Inc (SNDL) presents a solid investment opportunity as we head into February 2026, especially for investors seeking opportunities in the pharmaceuticals sector. With a market capitalization of roughly \\$422.3 million as of the end of January, SNDL is a small player with significant potential upsides.\n\nWhile SDNL doesn’t pay a shareholder dividend, this shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. While the current P\/E ratio is -6.3, (an improvement again from last month) the company is looking on track to be profitable this year with a high shareholder yield and strong liquid assets.\n\nSpeaking of risks, however, it’s important to note that SNDL operates in sectors characterized by regulatory volatility and competitive dynamics, which can lead to significant stock price fluctuations.\n\nDespite these challenges, SNDL has managed its debt levels effectively, ensuring financial stability as it explores new markets and products. This disciplined approach to expansion, combined with potential new legislative changes favoring cannabis legalization, could catalyze growth and enhance shareholder value. Overall, SNDL Inc. presents a dynamic investment opportunity for those looking to leverage the evolving landscape of the cannabis and alcohol sectors.\n\n## **Danaos Corp (**[**DAC**](https:\/\/www.investing.com\/equities\/danaos-corp)**):**\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy): Great\n- InvestingPro average fair value: \\$126.20 \/ 25.3% upside\n- Fair value confidence: High\n- Industry: Marine Transportation\n\nDanaos Corp (DAC) stands out as a noteworthy stock pick for February 2026, particularly for investors interested in the maritime shipping sector. As of the close of January, Danaos boasts a market capitalization of approximately \\$1.84 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics.\n\nDanaos offers an attractive dividend yield, currently at 3.6%, providing an added incentive for income-focused investors. The company maintains a P\/E ratio of 3.9, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 25% for those looking to capitalize on market inefficiencies.\n\nIn terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions.\n\nOverall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects.\n\n## ******LuLu Lemon ([LULU](https:\/\/www.investing.com\/equities\/lululemon-athletica))**:****\nCopied\n\n- [InvestingPro health score](https:\/\/www.investing.com\/pro\/NASDAQGS:LULU\/health?entry=academy): Good\n- InvestingPro average fair value: \\$290.94 \/ 52.3% upside\n- Fair value confidence: Medium\n- Industry: Textiles, Apparel & Luxury Goods\n\nFor investors targeting the consumer discretionary sector, Lululemon Athletica (LULU) presents a compelling growth story. As a global leader in athletic apparel and lifestyle products, the company boasts a substantial market capitalization of approximately \\$22.41 billion (as of the end of January 2026). Its current Price-to-Earnings (P\/E) ratio stands at 12.9, reflecting strong investor confidence in its future earnings potential and premium brand positioning, which was reinforced by solid performance in the last quarter.\n\nFinancially, Lululemon operates with a very strong balance sheet and minimal debt, allowing it to self-fund its aggressive expansion into new product categories and international markets. The company does not currently pay a dividend, instead prioritizing the reinvestment of profits to fuel this growth.\n\nAnalysts see a potential upside of just over 52% for the stock, driven by continued brand loyalty and successful market penetration. With a beta of 1.28, the stock exhibits a similar volatility (just slightly higher) than the overall market, which is uncharacteristic of a high-growth consumer brand. For investors with a long-term perspective, Lululemon’s powerful brand equity and consistent execution make it an attractive pick.\n\n## How To Find More Of The Best US Stocks\nCopied\n\nUse The InvestingPro Stock Screener To Outsmart The Market! 🛠️ 📈💸\n\nGain instant access to **over 1,200 fundamental metrics** for thousands of listed companies. Plus:\n\n✓ Easily and quickly find the best undervalued stocks for your portfolio\n\n✓ Competitor comparison tools\n\n✓ Evaluate stocks with 14+ proven financial models\n\n✓ Copy stock picks and weightings from top investors (including Warren Buffett)\n\n✓ Use filters to find stocks that perfectly match your strategy\n\n[Try InvestingPro and outsmart the market\\!](https:\/\/www.investing.com\/pro\/pricing?entry=academy)\n\n## **Previous Investing Stock Picks for US Markets**\nCopied\n\nIf you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months.\n\nRemember 📌\n\nThe health scores and these stocks’ place on our opportunities list were correct at the time of the original posting month. It’s important for investors to check any updated information, which can be done at the click of a button through [InvestingPro](https:\/\/www.investing.com\/pro?entry=academy).\n\nPrevious Top US Stocks to Watch in 2024\n\n| **Top November\/December 2024 Stock**s To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.97](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.48](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| White Mountain Insurance ([WTM](https:\/\/www.investing.com\/equities\/white-mountains-insurance-group)) | [3\\.27](https:\/\/www.investing.com\/pro\/NYSE:WTM\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.29](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| MI Homes ([MHO](https:\/\/www.investing.com\/equities\/m-i-homes-inc)) | [3\\.08](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top October 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.89](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.71](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| White Mountain Insurance ([WTM](https:\/\/www.investing.com\/equities\/white-mountains-insurance-group)) | [3\\.13](https:\/\/www.investing.com\/pro\/NYSE:WTM\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.47](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n\n| Top September 2024 Stocks To Watch | InvestingPro Health Score |\n|---|---|\n| **Top September Stock** | **InvestingPro Health Score** |\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.86](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.60](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| White Mountain Insurance ([WTM](https:\/\/www.investing.com\/equities\/white-mountains-insurance-group)) | [3\\.18](https:\/\/www.investing.com\/pro\/NYSE:WTM\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.35](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| KB Home ([KBH](https:\/\/www.investing.com\/equities\/kb-home)) | [3\\.23](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top August 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.94](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.73](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| Meritage Corporation ([MTH](https:\/\/www.investing.com\/equities\/meritage-homes-corp)) | [3\\.32](https:\/\/www.investing.com\/pro\/NYSE:MTH\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.57](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| KB Home ([KBH](https:\/\/www.investing.com\/equities\/kb-home)) | [3\\.38](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top July 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Harmony Biosciences ([HRMY](https:\/\/www.investing.com\/equities\/harmony-biosciences-holdings)) | [3\\.95](https:\/\/www.investing.com\/pro\/NASDAQGM:HRMY\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.80](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| Meritage Corporation ([MTH](https:\/\/www.investing.com\/equities\/meritage-homes-corp)) | [3\\.10](https:\/\/www.investing.com\/pro\/NYSE:MTH\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.75](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| KB Home ([KBH](https:\/\/www.investing.com\/equities\/kb-home)) | [3\\.38](https:\/\/www.investing.com\/pro\/NYSE:KBH\/health?entry=academy) \/ 5 |\n\n| Top June 2024 Stocks To Watch | InvestingPro Health Score |\n|---|---|\n| Tsakos Energy Nav. Ltd ([TNP](https:\/\/www.investing.com\/equities\/tsakos-energy-navigation-ltd)) | [3\\.33](https:\/\/www.investing.com\/pro\/NYSE:TNP\/health?entry=academy) \/ 5 |\n| International Seaways Inc ([INSW](https:\/\/www.investing.com\/equities\/international-seaways-inc)) | [3\\.86](https:\/\/www.investing.com\/pro\/NYSE:INSW\/health?entry=academy) \/ 5 |\n| Meritage Corporation ([MTH](https:\/\/www.investing.com\/equities\/meritage-homes-corp)) | [3\\.15](https:\/\/www.investing.com\/pro\/NYSE:MTH\/health?entry=academy) \/ 5 |\n| Danaos Corporation ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.87](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| CVR Partners ([UAN](https:\/\/www.investing.com\/equities\/cvr-partners-lp)) | [3\\.33](https:\/\/www.investing.com\/pro\/NYSE:UAN\/health?entry=academy) \/ 5 |\n\n| Top March 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Xpel Inc ([XPEL](https:\/\/www.investing.com\/equities\/xpel-inc)) | [3\\.14](https:\/\/www.investing.com\/pro\/NASDAQCM:XPEL\/health?entry=academy) \/ 5 |\n| Teekay Tankers ([TNK](https:\/\/www.investing.com\/equities\/teekay-tankers-ltd)) | [3\\.71](https:\/\/www.investing.com\/pro\/NYSE:TNK\/health?entry=academy) \/ 5 |\n| Simply Good Foods ([SMPL](https:\/\/www.investing.com\/equities\/simplicity)) | [3\\.02](https:\/\/www.investing.com\/pro\/NASDAQCM:SMPL\/health?entry=academy) \/ 5 |\n| United Therapeutics Corp ([UTHR](https:\/\/www.investing.com\/equities\/united-therapeutics-corp)) | [3\\.72](https:\/\/uk.investing.com\/pro\/NASDAQGS:UTHR\/health?entry=academy) \/ 5 |\n| The Andersons Inc ([ANDE](https:\/\/www.investing.com\/equities\/the-andersons)) | [3\\.31](https:\/\/uk.investing.com\/pro\/NASDAQGS:ANDE\/health?entry=academy) \/ 5 |\n\n| Top January 2024 Stocks To Watch | **InvestingPro Health Score** |\n|---|---|\n| Teekay Tankers ([TNK](https:\/\/www.investing.com\/equities\/teekay-tankers-ltd)) | [3\\.81](https:\/\/www.investing.com\/pro\/NYSE:TNK\/health?entry=academy) \/ 5 |\n| Mueller Industries ([MLI](https:\/\/www.investing.com\/equities\/mueller-industries-inc)) | [3\\.88](https:\/\/www.investing.com\/pro\/NYSE:MLI\/health?entry=academy) \/ 5 |\n| Danaos ([DAC](https:\/\/www.investing.com\/equities\/danaos-corp)) | [3\\.89](https:\/\/www.investing.com\/pro\/NYSE:DAC\/health?entry=academy) \/ 5 |\n| Medifast ([MED](https:\/\/www.investing.com\/equities\/medifast-inc)) | [3\\.30](https:\/\/www.investing.com\/pro\/NYSE:MED\/health?entry=academy) \/ 5 |\n| Daqo New Energy ([DQ](https:\/\/www.investing.com\/equities\/daqq-new-energy-corp)) | [3\\.89](https:\/\/www.investing.com\/pro\/NYSE:DQ\/health?entry=academy) \/ 5 |\n\nRemember 📌\n\nPast performance does not guarantee future success, and trading in financial instruments and\/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

27 days ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0.9 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.investing.com/academy/stock-picks/top-stocks-to-buy/
Last Crawled	2026-03-18 10:59:21 (27 days ago)
First Indexed	2023-08-31 17:24:12 (2 years ago)
HTTP Status Code	200
Meta Title	Top 5 US Stocks To Buy In February 2026 - Investing.com
Meta Description	Get information and actionable insights on the best top stocks to buy this month, based on multiple metrics and expert analysis.
Meta Canonical	null
Boilerpipe Text	Narrowing down the right stocks to buy based on multiple metrics is almost impossible without a solid methodology – which is where InvestingPro comes in. So what are the best stocks to add your watchlist for having solid financial health and growth opportunity? Read below to see which great stocks have been suggested this month by our InvestingPro AI/Analyst hybrid. Our top stock picks for this month are carefully selected to navigate stock market trends, opportunities and threats – continuing to focus on stocks that display strong fundamentals and resilience in the face of fluctuating economic conditions. Our Stock-Picking Methodology Copied Copy To Clipboard These 5 stocks are our top Pro Picks for this month, taken from S&P 500 -listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary fair value estimates (based on 5 overlaid investing models) and analyst assessments. Learn More 📜 The term “undervalued stocks” refers to stocks that are trading at a price below their intrinsic value or growth potential. Investors often look for undervalued stocks because, over the long term, the market will likely recognize the company’s true value, leading to a rise in the stock price and providing profit opportunities. All of these names have earned InvestingPro health scores of well above 3.00 (Good, Great or Excellent), which for the last 7 years has indicated outperformance vs. the S&P 500 . A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector. Copied Copy To Clipboard Best US Stocks This Month InvestingPro Health Score (Good, Great, or Excellent) Harmony Biosciences ( HRMY ) Excellent Cal-Main Foods Inc ( CALM ) Excellent SNDL Inc ( SNDL ) Great Danaos Corporation ( DAC ) Great LuLu Lemon ( LULU ) Good * All data correct as of January 28th, 2026 Importantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a current potential upside of more than 20% . So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration. Harmony Biosciences ( HRMY ): Copied Copy To Clipboard InvestingPro health score : Excellent InvestingPro average fair value: $51.37 / 39.5% upside Fair value confidence: High Industry: Healthcare / Pharmaceuticals Harmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for February 2026. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of January 2025, Harmony Biosciences has a market capitalization of approximately $2.12 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain. The company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P/E ratio is reported at 11.4, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 39.5% potential upside) due to anticipated product launches and expanding market reach. Harmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge. Overall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs. Cal-Maine Foods Inc ( CALM ): Copied Copy To Clipboard InvestingPro health score : Excellent InvestingPro average fair value: $102.12 / 26.9% upside Fair value confidence: High Industry: Consumer Staples / Food Products Cal-Maine Foods Inc earns their second month our list as stock pick for February 2026. As of the latest quarter, the company boasts a market capitalization of around $3.83 billion, marking it as a notable player in the consumer staples (food). Cal-Maine Foods specializes the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods. The company pays a quarterly dividend of (currently) 3.6%, providing investors with steady income alongside potential capital appreciation. With a P/E ratio of 3.3, Cal-Maine Foods appears relatively undervalued compared to industry peers, hinting at potential upside, especially if egg market production remains robust. Cal-Maine Foods maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 0.0% (which is common for them), which supports its operational diligence. Investors considering this stock should be aware of the volatility resilience associated with staple products, highlighted by their current 1-Year Beta of just 0.23. Overall, Cal-Maine Foods’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a resilient sector with the potential for both income and growth. SNDL Inc ( SNDL ): Copied Copy To Clipboard InvestingPro health score : Great InvestingPro average fair value: $2.35 / 43.2% upside Fair value confidence: Medium Industry: Healthcare / Pharmaceuticals SNDL Inc (SNDL) presents a solid investment opportunity as we head into February 2026, especially for investors seeking opportunities in the pharmaceuticals sector. With a market capitalization of roughly $422.3 million as of the end of January, SNDL is a small player with significant potential upsides. While SDNL doesn’t pay a shareholder dividend, this shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. While the current P/E ratio is -6.3, (an improvement again from last month) the company is looking on track to be profitable this year with a high shareholder yield and strong liquid assets. Speaking of risks, however, it’s important to note that SNDL operates in sectors characterized by regulatory volatility and competitive dynamics, which can lead to significant stock price fluctuations. Despite these challenges, SNDL has managed its debt levels effectively, ensuring financial stability as it explores new markets and products. This disciplined approach to expansion, combined with potential new legislative changes favoring cannabis legalization, could catalyze growth and enhance shareholder value. Overall, SNDL Inc. presents a dynamic investment opportunity for those looking to leverage the evolving landscape of the cannabis and alcohol sectors. Danaos Corp ( DAC ): Copied Copy To Clipboard InvestingPro health score : Great InvestingPro average fair value: $126.20 / 25.3% upside Fair value confidence: High Industry: Marine Transportation Danaos Corp (DAC) stands out as a noteworthy stock pick for February 2026, particularly for investors interested in the maritime shipping sector. As of the close of January, Danaos boasts a market capitalization of approximately $1.84 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics. Danaos offers an attractive dividend yield, currently at 3.6%, providing an added incentive for income-focused investors. The company maintains a P/E ratio of 3.9, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 25% for those looking to capitalize on market inefficiencies. In terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions. Overall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects. LuLu Lemon ( LULU ) : Copied Copy To Clipboard InvestingPro health score : Good InvestingPro average fair value: $290.94 / 52.3% upside Fair value confidence: Medium Industry: Textiles, Apparel & Luxury Goods For investors targeting the consumer discretionary sector, Lululemon Athletica (LULU) presents a compelling growth story. As a global leader in athletic apparel and lifestyle products, the company boasts a substantial market capitalization of approximately $22.41 billion (as of the end of January 2026). Its current Price-to-Earnings (P/E) ratio stands at 12.9, reflecting strong investor confidence in its future earnings potential and premium brand positioning, which was reinforced by solid performance in the last quarter. Financially, Lululemon operates with a very strong balance sheet and minimal debt, allowing it to self-fund its aggressive expansion into new product categories and international markets. The company does not currently pay a dividend, instead prioritizing the reinvestment of profits to fuel this growth. Analysts see a potential upside of just over 52% for the stock, driven by continued brand loyalty and successful market penetration. With a beta of 1.28, the stock exhibits a similar volatility (just slightly higher) than the overall market, which is uncharacteristic of a high-growth consumer brand. For investors with a long-term perspective, Lululemon’s powerful brand equity and consistent execution make it an attractive pick. How To Find More Of The Best US Stocks Copied Copy To Clipboard Use The InvestingPro Stock Screener To Outsmart The Market! 🛠️ 📈💸 Gain instant access to over 1,200 fundamental metrics for thousands of listed companies. Plus: ✓ Easily and quickly find the best undervalued stocks for your portfolio ✓ Competitor comparison tools ✓ Evaluate stocks with 14+ proven financial models ✓ Copy stock picks and weightings from top investors (including Warren Buffett) ✓ Use filters to find stocks that perfectly match your strategy Try InvestingPro and outsmart the market! Previous Investing Stock Picks for US Markets Copied Copy To Clipboard If you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months. Remember 📌 The health scores and these stocks’ place on our opportunities list were correct at the time of the original posting month. It’s important for investors to check any updated information, which can be done at the click of a button through InvestingPro . Previous Top US Stocks to Watch in 2024 Top November/December 2024 Stock s To Watch InvestingPro Health Score Harmony Biosciences ( HRMY ) 3.97 / 5 International Seaways Inc ( INSW ) 3.48 / 5 White Mountain Insurance ( WTM ) 3.27 / 5 Danaos Corporation ( DAC ) 3.29 / 5 MI Homes ( MHO ) 3.08 / 5 Top October 2024 Stocks To Watch InvestingPro Health Score Harmony Biosciences ( HRMY ) 3.89 / 5 International Seaways Inc ( INSW ) 3.71 / 5 White Mountain Insurance ( WTM ) 3.13 / 5 Danaos Corporation ( DAC ) 3.47 / 5 Top September 2024 Stocks To Watch InvestingPro Health Score Top September Stock InvestingPro Health Score Harmony Biosciences ( HRMY ) 3.86 / 5 International Seaways Inc ( INSW ) 3.60 / 5 White Mountain Insurance ( WTM ) 3.18 / 5 Danaos Corporation ( DAC ) 3.35 / 5 KB Home ( KBH ) 3.23 / 5 Top August 2024 Stocks To Watch InvestingPro Health Score Harmony Biosciences ( HRMY ) 3.94 / 5 International Seaways Inc ( INSW ) 3.73 / 5 Meritage Corporation ( MTH ) 3.32 / 5 Danaos Corporation ( DAC ) 3.57 / 5 KB Home ( KBH ) 3.38 / 5 Top July 2024 Stocks To Watch InvestingPro Health Score Harmony Biosciences ( HRMY ) 3.95 / 5 International Seaways Inc ( INSW ) 3.80 / 5 Meritage Corporation ( MTH ) 3.10 / 5 Danaos Corporation ( DAC ) 3.75 / 5 KB Home ( KBH ) 3.38 / 5 Top June 2024 Stocks To Watch InvestingPro Health Score Tsakos Energy Nav. Ltd ( TNP ) 3.33 / 5 International Seaways Inc ( INSW ) 3.86 / 5 Meritage Corporation ( MTH ) 3.15 / 5 Danaos Corporation ( DAC ) 3.87 / 5 CVR Partners ( UAN ) 3.33 / 5 Top March 2024 Stocks To Watch InvestingPro Health Score Xpel Inc ( XPEL ) 3.14 / 5 Teekay Tankers ( TNK ) 3.71 / 5 Simply Good Foods ( SMPL ) 3.02 / 5 United Therapeutics Corp ( UTHR ) 3.72 / 5 The Andersons Inc ( ANDE ) 3.31 / 5 Top January 2024 Stocks To Watch InvestingPro Health Score Teekay Tankers ( TNK ) 3.81 / 5 Mueller Industries ( MLI ) 3.88 / 5 Danaos ( DAC ) 3.89 / 5 Medifast ( MED ) 3.30 / 5 Daqo New Energy ( DQ ) 3.89 / 5 Remember 📌 Past performance does not guarantee future success, and trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Markdown	[Investing.com](https://www.investing.com/) - [Academy Center](https://www.investing.com/academy/) - [Markets](https://www.investing.com/markets/) - [News](https://www.investing.com/news) - [Analysis](https://www.investing.com/analysis) - [Charts](https://www.investing.com/charts) - [Technical](https://www.investing.com/technical/) - [Tools](https://www.investing.com/tools/) - [Watchlist](https://www.investing.com/portfolio/) - [Webinars](https://www.investing.com/education/webinars) - [InvestingPro](https://www.investing.com/pro?entry=academy) [Academy](https://www.investing.com/academy/) - [Stocks](https://www.investing.com/academy/stocks/) - [Crypto](https://www.investing.com/academy/crypto/) - [Trading](https://www.investing.com/academy/trading/) - [ETFs](https://www.investing.com/academy/etfs/) - [Currencies](https://www.investing.com/academy/currencies/) - [Analysis](https://www.investing.com/academy/analysis/) - [Statistics](https://www.investing.com/academy/statistics/) - [Stock Picks](https://www.investing.com/academy/stock-picks/) - [Financial Terms](https://www.investing.com/academy/financial-terms/) - [Global Stock Picks](https://www.investing.com/academy/global-stock-picks/) - [InvestingPro 101](https://www.investing.com/academy/investing-pro/) - [Tools](https://www.investing.com/academy/tools/) Table of contents - [Our Stock-Picking Methodology](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#our-stock-picking-methodology) - [5 Stocks To Consider In February 2026](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#5-stocks-to-consider-in-february-2026) - [Harmony Biosciences (HRMY):](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#harmony-biosciences-hrmy) - [Cal-Maine Foods Inc (CALM):](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#cal-maine-foods-inc-calm) - [SNDL Inc (SNDL):](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#sndl-inc-sndl) - [Danaos Corp (DAC):](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#danaos-corp-dac) - [LuLu Lemon (LULU):](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#lulu-lemon-lulu) - [How To Find More Of The Best US Stocks](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#how-to-find-more-of-the-best-us-stocks) - [Previous Investing Stock Picks for US Markets](https://www.investing.com/academy/stock-picks/top-stocks-to-buy/#previous-investing-stock-picks-for-us-markets) [Academy Center](https://www.investing.com/academy/) \> [Stock Picks](https://www.investing.com/academy/stock-picks/) Stock Picks Beginner # Top 5 US Stocks To Buy In February 2026 written by [Sara-Jayne Slack](https://www.investing.com/academy/author/sara-jayne-slack/) ![arrow-top](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/arrow-top.png) ![](https://academy.education.investing.com/wp-content/uploads/2023/08/Sara-Jayne.png) expertise: Wealth Management, Personal Finance currently: SEO Specialist (UK Market) \\| Investing.com education: BA & MA in English Studies, University of Leicester \\| Financial Markets and Investment Management, University of Geneva [See Full Bio](https://www.investing.com/academy/author/sara-jayne-slack/) \\| updated January 26, 2026 ![Blog header showing screenshot from InvestingPro with the blog title on the right](https://academy.education.investing.com/wp-content/uploads/2023/08/Top-Stocks-Monthly.png) Narrowing down the right stocks to buy based on multiple metrics is almost impossible without a solid methodology – which is where InvestingPro comes in. So what are the best stocks to add your watchlist for having solid financial health and growth opportunity? Read below to see which great stocks have been suggested this month by our InvestingPro AI/Analyst hybrid. Our top stock picks for this month are carefully selected to navigate stock market trends, opportunities and threats – continuing to focus on stocks that display strong fundamentals and resilience in the face of fluctuating economic conditions. ## Our Stock-Picking Methodology Copied These 5 stocks are our top Pro Picks for this month, taken from [S\&P 500](https://www.investing.com/indices/us-spx-500)\-listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary [fair value estimates](https://www.investing.com/academy/analysis/fair-value-investing-stocks/) (based on 5 overlaid investing models) and analyst assessments. Learn More 📜 The term “undervalued stocks” refers to stocks that are trading at a price below their intrinsic value or growth potential. Investors often look for undervalued stocks because, over the long term, the market will likely recognize the company’s true value, leading to a rise in the stock price and providing profit opportunities. All of these names have earned InvestingPro health scores of well above 3.00 (Good, Great or Excellent), which for the last 7 years has indicated outperformance vs. the S\&P 500. A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector. ## 5 Stocks To Consider In February 2026 Copied \| Best US Stocks This Month \| InvestingPro Health Score (Good, Great, or Excellent) \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [Excellent](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) \| \| Cal-Main Foods Inc ([CALM](https://www.investing.com/pro/NASDAQGS:CALM?entry=academy)) \| [Excellent](https://www.investing.com/pro/NASDAQGS:CALM/health?entry=academy) \| \| SNDL Inc ([SNDL](https://www.investing.com/equities/sundial-growers-inc)) \| [Great](https://www.investing.com/pro/NASDAQCM:SNDL/health?entry=academy) \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [Great](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) \| \| LuLu Lemon ([LULU](https://www.investing.com/equities/lululemon-athletica)) \| [Good](https://www.investing.com/pro/NASDAQGS:LULU/health?entry=academy) \| \* All data correct as of January 28th, 2026 Importantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a current potential upside of more than 20%. So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration. [![InvestingPro Cyber Monday 60% Off Banner](https://academy.education.investing.com/wp-content/uploads/2023/11/Maximize-Profit-Potential-Today-Banner.png)](https://www.investing.com/pro/pricing?entry=academy) ## **Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)): Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy): Excellent - InvestingPro average fair value: \$51.37 / 39.5% upside - Fair value confidence: High - Industry: Healthcare / Pharmaceuticals Harmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for February 2026. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of January 2025, Harmony Biosciences has a market capitalization of approximately \$2.12 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain. The company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P/E ratio is reported at 11.4, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 39.5% potential upside) due to anticipated product launches and expanding market reach. Harmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge. Overall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs. ## Cal-Maine Foods Inc ([CALM](https://www.investing.com/pro/NASDAQGS:CALM?entry=academy)): Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQGS:CALM/health?entry=academy): Excellent - InvestingPro average fair value: \$102.12 / 26.9% upside - Fair value confidence: High - Industry: Consumer Staples / Food Products Cal-Maine Foods Inc earns their second month our list as stock pick for February 2026. As of the latest quarter, the company boasts a market capitalization of around \$3.83 billion, marking it as a notable player in the consumer staples (food). Cal-Maine Foods specializes the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods. The company pays a quarterly dividend of (currently) 3.6%, providing investors with steady income alongside potential capital appreciation. With a P/E ratio of 3.3, Cal-Maine Foods appears relatively undervalued compared to industry peers, hinting at potential upside, especially if egg market production remains robust. Cal-Maine Foods maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 0.0% (which is common for them), which supports its operational diligence. Investors considering this stock should be aware of the volatility resilience associated with staple products, highlighted by their current 1-Year Beta of just 0.23. Overall, Cal-Maine Foods’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a resilient sector with the potential for both income and growth. ## SNDL Inc ([SNDL](https://www.investing.com/equities/sundial-growers-inc)): Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQCM:SNDL?entry=academy): Great - InvestingPro average fair value: \$2.35 / 43.2% upside - Fair value confidence: Medium - Industry: Healthcare / Pharmaceuticals SNDL Inc (SNDL) presents a solid investment opportunity as we head into February 2026, especially for investors seeking opportunities in the pharmaceuticals sector. With a market capitalization of roughly \$422.3 million as of the end of January, SNDL is a small player with significant potential upsides. While SDNL doesn’t pay a shareholder dividend, this shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. While the current P/E ratio is -6.3, (an improvement again from last month) the company is looking on track to be profitable this year with a high shareholder yield and strong liquid assets. Speaking of risks, however, it’s important to note that SNDL operates in sectors characterized by regulatory volatility and competitive dynamics, which can lead to significant stock price fluctuations. Despite these challenges, SNDL has managed its debt levels effectively, ensuring financial stability as it explores new markets and products. This disciplined approach to expansion, combined with potential new legislative changes favoring cannabis legalization, could catalyze growth and enhance shareholder value. Overall, SNDL Inc. presents a dynamic investment opportunity for those looking to leverage the evolving landscape of the cannabis and alcohol sectors. ## Danaos Corp ([DAC](https://www.investing.com/equities/danaos-corp)): Copied - [InvestingPro health score](https://www.investing.com/pro/NYSE:DAC/health?entry=academy): Great - InvestingPro average fair value: \$126.20 / 25.3% upside - Fair value confidence: High - Industry: Marine Transportation Danaos Corp (DAC) stands out as a noteworthy stock pick for February 2026, particularly for investors interested in the maritime shipping sector. As of the close of January, Danaos boasts a market capitalization of approximately \$1.84 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics. Danaos offers an attractive dividend yield, currently at 3.6%, providing an added incentive for income-focused investors. The company maintains a P/E ratio of 3.9, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 25% for those looking to capitalize on market inefficiencies. In terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions. Overall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects. ## **LuLu Lemon ([LULU](https://www.investing.com/equities/lululemon-athletica)):** Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQGS:LULU/health?entry=academy): Good - InvestingPro average fair value: \$290.94 / 52.3% upside - Fair value confidence: Medium - Industry: Textiles, Apparel & Luxury Goods For investors targeting the consumer discretionary sector, Lululemon Athletica (LULU) presents a compelling growth story. As a global leader in athletic apparel and lifestyle products, the company boasts a substantial market capitalization of approximately \$22.41 billion (as of the end of January 2026). Its current Price-to-Earnings (P/E) ratio stands at 12.9, reflecting strong investor confidence in its future earnings potential and premium brand positioning, which was reinforced by solid performance in the last quarter. Financially, Lululemon operates with a very strong balance sheet and minimal debt, allowing it to self-fund its aggressive expansion into new product categories and international markets. The company does not currently pay a dividend, instead prioritizing the reinvestment of profits to fuel this growth. Analysts see a potential upside of just over 52% for the stock, driven by continued brand loyalty and successful market penetration. With a beta of 1.28, the stock exhibits a similar volatility (just slightly higher) than the overall market, which is uncharacteristic of a high-growth consumer brand. For investors with a long-term perspective, Lululemon’s powerful brand equity and consistent execution make it an attractive pick. ## How To Find More Of The Best US Stocks Copied Use The InvestingPro Stock Screener To Outsmart The Market! 🛠️ 📈💸 Gain instant access to over 1,200 fundamental metrics for thousands of listed companies. Plus: ✓ Easily and quickly find the best undervalued stocks for your portfolio ✓ Competitor comparison tools ✓ Evaluate stocks with 14+ proven financial models ✓ Copy stock picks and weightings from top investors (including Warren Buffett) ✓ Use filters to find stocks that perfectly match your strategy [Try InvestingPro and outsmart the market\!](https://www.investing.com/pro/pricing?entry=academy) ## Previous Investing Stock Picks for US Markets Copied If you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months. Remember 📌 The health scores and these stocks’ place on our opportunities list were correct at the time of the original posting month. It’s important for investors to check any updated information, which can be done at the click of a button through [InvestingPro](https://www.investing.com/pro?entry=academy). ### Previous Top US Stocks to Watch in 2024 \| Top November/December 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.97](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.48](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| White Mountain Insurance ([WTM](https://www.investing.com/equities/white-mountains-insurance-group)) \| [3\.27](https://www.investing.com/pro/NYSE:WTM/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.29](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| MI Homes ([MHO](https://www.investing.com/equities/m-i-homes-inc)) \| [3\.08](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top October 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.89](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.71](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| White Mountain Insurance ([WTM](https://www.investing.com/equities/white-mountains-insurance-group)) \| [3\.13](https://www.investing.com/pro/NYSE:WTM/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.47](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| Top September 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Top September Stock \| InvestingPro Health Score \| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.86](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.60](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| White Mountain Insurance ([WTM](https://www.investing.com/equities/white-mountains-insurance-group)) \| [3\.18](https://www.investing.com/pro/NYSE:WTM/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.35](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| KB Home ([KBH](https://www.investing.com/equities/kb-home)) \| [3\.23](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top August 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.94](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.73](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| Meritage Corporation ([MTH](https://www.investing.com/equities/meritage-homes-corp)) \| [3\.32](https://www.investing.com/pro/NYSE:MTH/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.57](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| KB Home ([KBH](https://www.investing.com/equities/kb-home)) \| [3\.38](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top July 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.95](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.80](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| Meritage Corporation ([MTH](https://www.investing.com/equities/meritage-homes-corp)) \| [3\.10](https://www.investing.com/pro/NYSE:MTH/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.75](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| KB Home ([KBH](https://www.investing.com/equities/kb-home)) \| [3\.38](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top June 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Tsakos Energy Nav. Ltd ([TNP](https://www.investing.com/equities/tsakos-energy-navigation-ltd)) \| [3\.33](https://www.investing.com/pro/NYSE:TNP/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.86](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| Meritage Corporation ([MTH](https://www.investing.com/equities/meritage-homes-corp)) \| [3\.15](https://www.investing.com/pro/NYSE:MTH/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.87](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| CVR Partners ([UAN](https://www.investing.com/equities/cvr-partners-lp)) \| [3\.33](https://www.investing.com/pro/NYSE:UAN/health?entry=academy) / 5 \| \| Top March 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Xpel Inc ([XPEL](https://www.investing.com/equities/xpel-inc)) \| [3\.14](https://www.investing.com/pro/NASDAQCM:XPEL/health?entry=academy) / 5 \| \| Teekay Tankers ([TNK](https://www.investing.com/equities/teekay-tankers-ltd)) \| [3\.71](https://www.investing.com/pro/NYSE:TNK/health?entry=academy) / 5 \| \| Simply Good Foods ([SMPL](https://www.investing.com/equities/simplicity)) \| [3\.02](https://www.investing.com/pro/NASDAQCM:SMPL/health?entry=academy) / 5 \| \| United Therapeutics Corp ([UTHR](https://www.investing.com/equities/united-therapeutics-corp)) \| [3\.72](https://uk.investing.com/pro/NASDAQGS:UTHR/health?entry=academy) / 5 \| \| The Andersons Inc ([ANDE](https://www.investing.com/equities/the-andersons)) \| [3\.31](https://uk.investing.com/pro/NASDAQGS:ANDE/health?entry=academy) / 5 \| \| Top January 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Teekay Tankers ([TNK](https://www.investing.com/equities/teekay-tankers-ltd)) \| [3\.81](https://www.investing.com/pro/NYSE:TNK/health?entry=academy) / 5 \| \| Mueller Industries ([MLI](https://www.investing.com/equities/mueller-industries-inc)) \| [3\.88](https://www.investing.com/pro/NYSE:MLI/health?entry=academy) / 5 \| \| Danaos ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.89](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| Medifast ([MED](https://www.investing.com/equities/medifast-inc)) \| [3\.30](https://www.investing.com/pro/NYSE:MED/health?entry=academy) / 5 \| \| Daqo New Energy ([DQ](https://www.investing.com/equities/daqq-new-energy-corp)) \| [3\.89](https://www.investing.com/pro/NYSE:DQ/health?entry=academy) / 5 \| Remember 📌 Past performance does not guarantee future success, and trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. - Related - Recent [![]()](https://www.investing.com/pro/pricing?entry=academy) ## Recent Articles [![](https://academy.education.investing.com/wp-content/uploads/2025/12/Top-10-Stocks-For-2026-150x150.png) Top 10 Stocks for 2026: Live Expert Analysis & Free Stock List While most investors chase the last AI winners of 2025, smart money is quietly rotating into completely different opportunities for 2026. The next 30 days](https://www.investing.com/academy/stock-picks/top-ten-2026-stocks/) [![](https://academy.education.investing.com/wp-content/uploads/2025/08/amd-image-150x150.jpg) Nvidia vs AMD: Stock Comparison Investing in technology stocks requires understanding not just current performance metrics but the fundamental strengths, market positioning, and long term potential of companies. When considering](https://www.investing.com/academy/stock-picks/nvidia-vs-amd/) [![](https://academy.education.investing.com/wp-content/uploads/2025/08/nvidia-vs-broadcom-150x150.jpg) Nvidia vs Broadcom Stock Comparison When navigating the semiconductor industry for investment opportunities, Nvidia and Broadcom often emerge as leading contenders for investor portfolios. Both companies represent significant forces in](https://www.investing.com/academy/stock-picks/nvidia-vs-broadcom/) [![](https://academy.education.investing.com/wp-content/uploads/2025/08/berkshire-hathaway-150x150.jpg) Berkshire Hathaway Class A vs. Class B: Understanding the Differences For investors interested in owning a piece of a legendary company like Berkshire Hathaway, the choice often comes down to two different share classes: Class](https://www.investing.com/academy/stock-picks/berkshire-hathaway-class-a-vs-class-b/) * ### Install Our Apps Scan the QR code or install from the link [![www.facebook.com](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/icon-apple.svg)App Store](https://app.appsflyer.com/id909998122?pid=direct_inv&c=refactored&af_channel=%2F&af_adset=www&af_ad=footer&af_pmod_priority=null&af_sub_siteid=GA1.1.1440476105.1724666634&click_id=null&af_sub1=null&af_ad_id=null&af_sub2=null&af_sub3=null&af_sub4=null&af_sub5=null&af_keywords=null&af_adset_id=null) [![www.twitter.com](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/icon-google-play.svg)Google Play](https://app.appsflyer.com/com.fusionmedia.investing?pid=direct_inv&c=refactored&af_channel=%2F&af_adset=www&af_ad=footer&af_pmod_priority=null&af_sub_siteid=GA1.1.1440476105.1724666634&click_id=null&af_sub1=null&af_ad_id=null&af_sub2=null&af_sub3=null&af_sub4=null&af_sub5=null&af_keywords=null&af_adset_id=null) * ![www.investing.com](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/QR-Code.svg) - [Blog](https://www.investing.com/blog) - [Mobile](https://www.investing.com/mobile) - [Portfolio](https://www.investing.com/portfolio) - [Widgets](https://www.investing.com/webmaster-tools) - [About Us](https://www.investing.com/about-us) - [Advertise](https://www.investingmediakit.com/) - [Help & Support](https://www.investing.com/about-us/contact-us) - [Authors](https://www.investing.com/lp/authors) ![Investing.com](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/logo.png) [![www.facebook.com](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/icon-facebook.svg)](https://www.facebook.com/investingcom/) [![www.twitter.com](https://academy.education.investing.com/wp-content/themes/Ancelotti/includes/images/icon-twitter.svg)](https://www.twitter.com/investingcom) Risk Disclosure: Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers. Fusion Media does not endorse any product or service and does not assume any liability regarding your interaction with any third party displayed on this site, including the nature, quality, supply or fitness for a particular purpose of the product or service, or any damage caused as a result of the use of such product or service. * © 2007-2026 Fusion Media Limited. All Rights Reserved - [Terms And Conditions](https://www.investing.com/about-us/terms-and-conditions/) - [Privacy Policy](https://www.investing.com/about-us/privacy-policy/) - [Risk Warning](https://www.investing.com/about-us/risk-warning/) - [Cookie Preferences]()
Readable Markdown	Narrowing down the right stocks to buy based on multiple metrics is almost impossible without a solid methodology – which is where InvestingPro comes in. So what are the best stocks to add your watchlist for having solid financial health and growth opportunity? Read below to see which great stocks have been suggested this month by our InvestingPro AI/Analyst hybrid. Our top stock picks for this month are carefully selected to navigate stock market trends, opportunities and threats – continuing to focus on stocks that display strong fundamentals and resilience in the face of fluctuating economic conditions. ## Our Stock-Picking Methodology Copied These 5 stocks are our top Pro Picks for this month, taken from [S\&P 500](https://www.investing.com/indices/us-spx-500)\-listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary [fair value estimates](https://www.investing.com/academy/analysis/fair-value-investing-stocks/) (based on 5 overlaid investing models) and analyst assessments. Learn More 📜 The term “undervalued stocks” refers to stocks that are trading at a price below their intrinsic value or growth potential. Investors often look for undervalued stocks because, over the long term, the market will likely recognize the company’s true value, leading to a rise in the stock price and providing profit opportunities. All of these names have earned InvestingPro health scores of well above 3.00 (Good, Great or Excellent), which for the last 7 years has indicated outperformance vs. the S\&P 500. A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector. Copied \| Best US Stocks This Month \| InvestingPro Health Score (Good, Great, or Excellent) \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [Excellent](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) \| \| Cal-Main Foods Inc ([CALM](https://www.investing.com/pro/NASDAQGS:CALM?entry=academy)) \| [Excellent](https://www.investing.com/pro/NASDAQGS:CALM/health?entry=academy) \| \| SNDL Inc ([SNDL](https://www.investing.com/equities/sundial-growers-inc)) \| [Great](https://www.investing.com/pro/NASDAQCM:SNDL/health?entry=academy) \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [Great](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) \| \| LuLu Lemon ([LULU](https://www.investing.com/equities/lululemon-athletica)) \| [Good](https://www.investing.com/pro/NASDAQGS:LULU/health?entry=academy) \| \* All data correct as of January 28th, 2026 Importantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a current potential upside of more than 20%. So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration. [![InvestingPro Cyber Monday 60% Off Banner](https://academy.education.investing.com/wp-content/uploads/2023/11/Maximize-Profit-Potential-Today-Banner.png)](https://www.investing.com/pro/pricing?entry=academy) ## **Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)): Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy): Excellent - InvestingPro average fair value: \$51.37 / 39.5% upside - Fair value confidence: High - Industry: Healthcare / Pharmaceuticals Harmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for February 2026. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of January 2025, Harmony Biosciences has a market capitalization of approximately \$2.12 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain. The company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P/E ratio is reported at 11.4, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 39.5% potential upside) due to anticipated product launches and expanding market reach. Harmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge. Overall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs. ## Cal-Maine Foods Inc ([CALM](https://www.investing.com/pro/NASDAQGS:CALM?entry=academy)): Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQGS:CALM/health?entry=academy): Excellent - InvestingPro average fair value: \$102.12 / 26.9% upside - Fair value confidence: High - Industry: Consumer Staples / Food Products Cal-Maine Foods Inc earns their second month our list as stock pick for February 2026. As of the latest quarter, the company boasts a market capitalization of around \$3.83 billion, marking it as a notable player in the consumer staples (food). Cal-Maine Foods specializes the production, grading, packaging, marketing, and distribution of shell eggs, egg products, and prepared foods. The company pays a quarterly dividend of (currently) 3.6%, providing investors with steady income alongside potential capital appreciation. With a P/E ratio of 3.3, Cal-Maine Foods appears relatively undervalued compared to industry peers, hinting at potential upside, especially if egg market production remains robust. Cal-Maine Foods maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 0.0% (which is common for them), which supports its operational diligence. Investors considering this stock should be aware of the volatility resilience associated with staple products, highlighted by their current 1-Year Beta of just 0.23. Overall, Cal-Maine Foods’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a resilient sector with the potential for both income and growth. ## SNDL Inc ([SNDL](https://www.investing.com/equities/sundial-growers-inc)): Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQCM:SNDL?entry=academy): Great - InvestingPro average fair value: \$2.35 / 43.2% upside - Fair value confidence: Medium - Industry: Healthcare / Pharmaceuticals SNDL Inc (SNDL) presents a solid investment opportunity as we head into February 2026, especially for investors seeking opportunities in the pharmaceuticals sector. With a market capitalization of roughly \$422.3 million as of the end of January, SNDL is a small player with significant potential upsides. While SDNL doesn’t pay a shareholder dividend, this shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. While the current P/E ratio is -6.3, (an improvement again from last month) the company is looking on track to be profitable this year with a high shareholder yield and strong liquid assets. Speaking of risks, however, it’s important to note that SNDL operates in sectors characterized by regulatory volatility and competitive dynamics, which can lead to significant stock price fluctuations. Despite these challenges, SNDL has managed its debt levels effectively, ensuring financial stability as it explores new markets and products. This disciplined approach to expansion, combined with potential new legislative changes favoring cannabis legalization, could catalyze growth and enhance shareholder value. Overall, SNDL Inc. presents a dynamic investment opportunity for those looking to leverage the evolving landscape of the cannabis and alcohol sectors. ## Danaos Corp ([DAC](https://www.investing.com/equities/danaos-corp)): Copied - [InvestingPro health score](https://www.investing.com/pro/NYSE:DAC/health?entry=academy): Great - InvestingPro average fair value: \$126.20 / 25.3% upside - Fair value confidence: High - Industry: Marine Transportation Danaos Corp (DAC) stands out as a noteworthy stock pick for February 2026, particularly for investors interested in the maritime shipping sector. As of the close of January, Danaos boasts a market capitalization of approximately \$1.84 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics. Danaos offers an attractive dividend yield, currently at 3.6%, providing an added incentive for income-focused investors. The company maintains a P/E ratio of 3.9, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 25% for those looking to capitalize on market inefficiencies. In terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions. Overall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects. ## **LuLu Lemon ([LULU](https://www.investing.com/equities/lululemon-athletica)):** Copied - [InvestingPro health score](https://www.investing.com/pro/NASDAQGS:LULU/health?entry=academy): Good - InvestingPro average fair value: \$290.94 / 52.3% upside - Fair value confidence: Medium - Industry: Textiles, Apparel & Luxury Goods For investors targeting the consumer discretionary sector, Lululemon Athletica (LULU) presents a compelling growth story. As a global leader in athletic apparel and lifestyle products, the company boasts a substantial market capitalization of approximately \$22.41 billion (as of the end of January 2026). Its current Price-to-Earnings (P/E) ratio stands at 12.9, reflecting strong investor confidence in its future earnings potential and premium brand positioning, which was reinforced by solid performance in the last quarter. Financially, Lululemon operates with a very strong balance sheet and minimal debt, allowing it to self-fund its aggressive expansion into new product categories and international markets. The company does not currently pay a dividend, instead prioritizing the reinvestment of profits to fuel this growth. Analysts see a potential upside of just over 52% for the stock, driven by continued brand loyalty and successful market penetration. With a beta of 1.28, the stock exhibits a similar volatility (just slightly higher) than the overall market, which is uncharacteristic of a high-growth consumer brand. For investors with a long-term perspective, Lululemon’s powerful brand equity and consistent execution make it an attractive pick. ## How To Find More Of The Best US Stocks Copied Use The InvestingPro Stock Screener To Outsmart The Market! 🛠️ 📈💸 Gain instant access to over 1,200 fundamental metrics for thousands of listed companies. Plus: ✓ Easily and quickly find the best undervalued stocks for your portfolio ✓ Competitor comparison tools ✓ Evaluate stocks with 14+ proven financial models ✓ Copy stock picks and weightings from top investors (including Warren Buffett) ✓ Use filters to find stocks that perfectly match your strategy [Try InvestingPro and outsmart the market\!](https://www.investing.com/pro/pricing?entry=academy) ## Previous Investing Stock Picks for US Markets Copied If you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months. Remember 📌 The health scores and these stocks’ place on our opportunities list were correct at the time of the original posting month. It’s important for investors to check any updated information, which can be done at the click of a button through [InvestingPro](https://www.investing.com/pro?entry=academy). Previous Top US Stocks to Watch in 2024 \| Top November/December 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.97](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.48](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| White Mountain Insurance ([WTM](https://www.investing.com/equities/white-mountains-insurance-group)) \| [3\.27](https://www.investing.com/pro/NYSE:WTM/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.29](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| MI Homes ([MHO](https://www.investing.com/equities/m-i-homes-inc)) \| [3\.08](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top October 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.89](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.71](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| White Mountain Insurance ([WTM](https://www.investing.com/equities/white-mountains-insurance-group)) \| [3\.13](https://www.investing.com/pro/NYSE:WTM/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.47](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| Top September 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Top September Stock \| InvestingPro Health Score \| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.86](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.60](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| White Mountain Insurance ([WTM](https://www.investing.com/equities/white-mountains-insurance-group)) \| [3\.18](https://www.investing.com/pro/NYSE:WTM/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.35](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| KB Home ([KBH](https://www.investing.com/equities/kb-home)) \| [3\.23](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top August 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.94](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.73](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| Meritage Corporation ([MTH](https://www.investing.com/equities/meritage-homes-corp)) \| [3\.32](https://www.investing.com/pro/NYSE:MTH/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.57](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| KB Home ([KBH](https://www.investing.com/equities/kb-home)) \| [3\.38](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top July 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Harmony Biosciences ([HRMY](https://www.investing.com/equities/harmony-biosciences-holdings)) \| [3\.95](https://www.investing.com/pro/NASDAQGM:HRMY/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.80](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| Meritage Corporation ([MTH](https://www.investing.com/equities/meritage-homes-corp)) \| [3\.10](https://www.investing.com/pro/NYSE:MTH/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.75](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| KB Home ([KBH](https://www.investing.com/equities/kb-home)) \| [3\.38](https://www.investing.com/pro/NYSE:KBH/health?entry=academy) / 5 \| \| Top June 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Tsakos Energy Nav. Ltd ([TNP](https://www.investing.com/equities/tsakos-energy-navigation-ltd)) \| [3\.33](https://www.investing.com/pro/NYSE:TNP/health?entry=academy) / 5 \| \| International Seaways Inc ([INSW](https://www.investing.com/equities/international-seaways-inc)) \| [3\.86](https://www.investing.com/pro/NYSE:INSW/health?entry=academy) / 5 \| \| Meritage Corporation ([MTH](https://www.investing.com/equities/meritage-homes-corp)) \| [3\.15](https://www.investing.com/pro/NYSE:MTH/health?entry=academy) / 5 \| \| Danaos Corporation ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.87](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| CVR Partners ([UAN](https://www.investing.com/equities/cvr-partners-lp)) \| [3\.33](https://www.investing.com/pro/NYSE:UAN/health?entry=academy) / 5 \| \| Top March 2024 Stocks To Watch \| InvestingPro Health Score \| \|---\|---\| \| Xpel Inc ([XPEL](https://www.investing.com/equities/xpel-inc)) \| [3\.14](https://www.investing.com/pro/NASDAQCM:XPEL/health?entry=academy) / 5 \| \| Teekay Tankers ([TNK](https://www.investing.com/equities/teekay-tankers-ltd)) \| [3\.71](https://www.investing.com/pro/NYSE:TNK/health?entry=academy) / 5 \| \| Simply Good Foods ([SMPL](https://www.investing.com/equities/simplicity)) \| [3\.02](https://www.investing.com/pro/NASDAQCM:SMPL/health?entry=academy) / 5 \| \| United Therapeutics Corp ([UTHR](https://www.investing.com/equities/united-therapeutics-corp)) \| [3\.72](https://uk.investing.com/pro/NASDAQGS:UTHR/health?entry=academy) / 5 \| \| The Andersons Inc ([ANDE](https://www.investing.com/equities/the-andersons)) \| [3\.31](https://uk.investing.com/pro/NASDAQGS:ANDE/health?entry=academy) / 5 \| \| Top January 2024 Stocks To Watch \| InvestingPro Health Score** \| \|---\|---\| \| Teekay Tankers ([TNK](https://www.investing.com/equities/teekay-tankers-ltd)) \| [3\.81](https://www.investing.com/pro/NYSE:TNK/health?entry=academy) / 5 \| \| Mueller Industries ([MLI](https://www.investing.com/equities/mueller-industries-inc)) \| [3\.88](https://www.investing.com/pro/NYSE:MLI/health?entry=academy) / 5 \| \| Danaos ([DAC](https://www.investing.com/equities/danaos-corp)) \| [3\.89](https://www.investing.com/pro/NYSE:DAC/health?entry=academy) / 5 \| \| Medifast ([MED](https://www.investing.com/equities/medifast-inc)) \| [3\.30](https://www.investing.com/pro/NYSE:MED/health?entry=academy) / 5 \| \| Daqo New Energy ([DQ](https://www.investing.com/equities/daqq-new-energy-corp)) \| [3\.89](https://www.investing.com/pro/NYSE:DQ/health?entry=academy) / 5 \| Remember 📌 Past performance does not guarantee future success, and trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Shard	154 (laksa)
Root Hash	11324614435800175354
Unparsed URL	com,investing!www,/academy/stock-picks/top-stocks-to-buy/ s443